Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Physiologica Sinica ; (6): 707-722, 2021.
Article Dans Chinois | WPRIM | ID: wpr-921274

Résumé

Glucose and lipid metabolism is the most fundamental metabolic activity of higher organisms. This process is affected by both genetic polymorphisms and environmental factors. Excessive uptake and accumulation of lipids lead to obesity and disorder of glucose metabolic homeostasis characterized by insulin resistance and hyperglycemia, suggesting that the cross-regulation between lipid and glucose metabolism happens precisely at organ, cellular and molecular levels by known mechanisms. Adenine nucleotides and their metabolites have emerged as mediators in the mutual regulation of glucose and lipid metabolism. This review summarizes the roles of purinergic signaling induced by fatty acids in glucose metabolism and the development of type 2 diabetes.


Sujets)
Humains , Nucléotides adényliques , Diabète de type 2 , Glucose , Homéostasie , Insulinorésistance , Métabolisme lipidique
2.
Acta Pharmaceutica Sinica ; (12): 1152-1156, 2008.
Article Dans Chinois | WPRIM | ID: wpr-232626

Résumé

The in vitro release behavior, in vivo biodistribution and antitumor activity of N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-5-fluorouracil conjugates (P-FU) were studied. The in vitro release behavior was evaluated by determining the amount of 5-fluorouracil (5-FU) released from P-FU in mice plasma at 37 degrees C. The in vivo biodistribution and therapeutic evaluation were investigated with Kunming mice bearing hepatoma 22 (H22). The in vitro half-life (t1/2) of P-FU in mice plasma was 32.4 h. It appeared that the circulation life time of the conjugates were 166 times longer than that of 5-FU. The AUC and t1/2 of P-FU in tumor were 3.3 times and 2.3 times more than those of 5-FU, respectively. Therapeutic evaluation also demonstrated that the treatment with P-FU displayed stronger inhibition of the tumor growth when compared with that of 5-FU (P < 0.05). HPMA copolymer is a potential carrier for 5-FU for effective treatment of cancer.


Sujets)
Animaux , Femelle , Souris , Acrylamides , Pharmacocinétique , Pharmacologie , Antimétabolites antinéoplasiques , Pharmacocinétique , Pharmacologie , Aire sous la courbe , Lignée cellulaire tumorale , Vecteurs de médicaments , Préparation de médicament , Fluorouracil , Pharmacocinétique , Pharmacologie , Tumeurs expérimentales du foie , Métabolisme , Anatomopathologie , Transplantation tumorale , Répartition aléatoire , Distribution tissulaire , Charge tumorale
SÉLECTION CITATIONS
Détails de la recherche